Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children

M E Paul1, W T Shearer, C A Kozinetz

  • 1Baylor College of Medicine, Houston, TX, USA.

Insights

In pediatric HIV infection, CD8(+) T cells show activation and loss of CD28, correlating with faster disease progression. These changes in immune cells offer insights into HIV management in children.

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Background:

  • CD8(+) T-cell subsets are not well-characterized in pediatric HIV infection, particularly distinguishing rapid progressors (RPs) from non-rapid progressors (non-RPs).
  • Understanding these immune cell differences is crucial for assessing disease progression and informing treatment strategies in children living with HIV.

Purpose of the Study:

  • To investigate the distribution of specific CD8(+) T-cell subsets in HIV-infected children.
  • To correlate these T-cell subset findings with indicators of disease severity, such as immunosuppression (CD4(+) T-cell percentages) and HIV viral load (RNA levels).

Main Methods:

  • Utilized 3-color flow cytometry to analyze percentages of CD38(+)DR(+), CD28(+), and CD57(+) CD8(+) T-cell subsets.
  • Compared these subsets across rapid progressors (RPs), non-rapid progressors (non-RPs), HIV-exposed but uninfected children, and HIV-unexposed children.
  • Correlated T-cell subset data with CD4(+) T-cell percentages and HIV RNA levels, controlling for age using analysis of covariance.

Main Results:

  • HIV-exposed and unexposed children showed similar CD8(+) T-cell subset distributions, with minor differences in DR(-)CD38(+)CD8(+) T cells.
  • Rapid progressors (RPs) exhibited a higher percentage of DR(+)CD38(+)CD8(+) T cells and increased viremia compared to non-RPs and controls.
  • CD28(+)CD8(+) T-cell percentages were lower in HIV-infected children, and CD28(+)CD57(-)CD8(+) T cells positively correlated with CD4(+) T-cell percentages in infected groups.

Conclusions:

  • CD8(+) T cells in pediatric HIV infection demonstrate activation (DR and CD38 co-expression) and CD28 loss, with some acquiring CD57.
  • These immune cell alterations are linked to the pace of disease progression in children with HIV.
  • Findings highlight specific CD8(+) T-cell subset changes as potential biomarkers for disease activity in pediatric HIV.
Abstract

Related Concept Videos